On the other hand, we found that none of the breast cancer cell lines tested showed upregulated TCF/LEF transcriptional activity, even when they showed a loss of Wnt antagonist genes and nuclear accumulation of β-catenin, which is consistent with our earlier findings in GC cells. This evidence concerns the gene HNF4A and breast carcinoma.